22 results on '"Jong, P.E. de"'
Search Results
2. Development and Validation of a General Population Renal Risk Score
- Author
-
Halbesma, N., Jansen, D.F., Heymans, M.W., Stolk, R.P., Jong, P.E. de, Gansevoort, R.T., PREVEND Study Grp, Life Course Epidemiology (LCE), Cardiovascular Centre (CVC), Lifestyle Medicine (LM), Groningen Kidney Center (GKC), Methodology and Applied Biostatistics, EMGO+ - Musculoskeletal Health, Epidemiology and Data Science, and EMGO - Musculoskeletal health
- Subjects
Male ,CHRONIC KIDNEY-DISEASE ,Time Factors ,Epidemiology ,Blood Pressure ,PROGRESSION ,Kidney ,urologic and male genital diseases ,Critical Care and Intensive Care Medicine ,Logistic regression ,Risk Factors ,Statistics ,Odds Ratio ,Health Status Indicators ,Prospective Studies ,PREDICTORS ,Prospective cohort study ,Netherlands ,education.field_of_study ,Framingham Risk Score ,Age Factors ,Middle Aged ,PREVALENCE ,C-Reactive Protein ,Nephrology ,Hypertension ,Disease Progression ,Female ,Kidney Diseases ,Glomerular Filtration Rate ,Cohort study ,Adult ,NATIONAL-HEALTH ,medicine.medical_specialty ,NEPHROPATHY ,MODELS ,Population ,UNITED-STATES ,Risk Assessment ,SDG 17 - Partnerships for the Goals ,Predictive Value of Tests ,Internal medicine ,medicine ,Albuminuria ,Humans ,education ,Aged ,Transplantation ,Receiver operating characteristic ,business.industry ,Reproducibility of Results ,Odds ratio ,medicine.disease ,Logistic Models ,ROC Curve ,Chronic Disease ,business ,Biomarkers ,Kidney disease - Abstract
There is a need for prediction scores that identify individuals at increased risk for developing progressive chronic kidney disease (CKD). Therefore, this study was performed to develop and validate a "renal risk score" for the general population. Design, setting, participants,measurements For this study we used data from the PREVEND (Prevention of Renal and Vascular ENdstage Disease) study, a prospective population-based cohort study with a median follow-up of 6.4 years. Participants with two or three consecutive estimated GFR (eGFR) measurements during follow-up were included. Participants within the group who had the most renal function decline (top 20% of the total population) and had an eGFR value60 ml/min per 1.73 m² during follow-up were defined as having progressive CKD. Possible predictors for progressive CKD were selected on the basis of univariable logistic regression analyses.A final prediction model was built using backward logistic regression analysis. Besides baseline eGFR, the model contained age, urinary albumin excretion, systolic BP, C-reactive protein, and known hypertension. The area under the receiver operating characteristic (ROC) curve was 0.84. We performed internal validation by using a bootstrapping procedure. As expected, after the regression coefficients were corrected for optimism, the area under the ROC curve was still 0.84. For clinical use we divided all predictors in meaningful clinical categories to develop a score chart. The area under the ROC curve was 0.83, indicating the high discriminative value of this model.Given the high internal validity of this renal risk score, this score can be helpful to identify individuals at increased risk for progressive CKD.
- Published
- 2011
- Full Text
- View/download PDF
3. [Population screening for urinary protein loss: a sensible action]
- Author
-
Jong, P.E. de, Gansevoort, R.T., and Wetzels, J.F.M.
- Subjects
Renal disorders [UMCN 5.4] ,Iron metabolism [IGMD 7] ,urologic and male genital diseases ,Renal disorder [IGMD 9] - Abstract
Item does not contain fulltext In 2006, the Dutch Nierstichting (Kidney Foundation) provided people with urinary dipsticks to determine whether they suffered from urinary protein loss. It was suspected that 0.5% of adult inhabitants would have hidden renal disease. Within two weeks, more than one million people had applied to receive the dipsticks. They were advised to contact their general practitioner if they tested positive. Blockade of the renin-angiotensin-aldosterone system (RAAS) in subjects with known renal disease and proteinuria improves renal and cardiac survival. However, many patients currently develop end-stage renal disease without prior knowledge ofhaving chronic kidney disease. These patients can be detected by screening for proteinuria or albuminuria. Japanese studies showed that about 5% of the general population have positive dipstick tests. It is to be expected that about 1% will be truly macroalbuminuric and another 2-3% will be microalbuminuric. Macroalbuminuria is the consequence of manifest glomerular damage, while microalbuminuria is in most cases related to underlying diabetes or hypertension (which frequently are not yet diagnosed). In both conditions, treatment with RAAS blockade is indicated and is aimed at both cardiac and renal protection. There are arguments indicating that screening of the general population for urinary protein loss is cost-effective.
- Published
- 2007
4. Stability of creatinine and cystatin C in whole blood
- Author
-
Spithoven, E.M., Bakker, S.J., Kootstra-Ros, J.E., Jong, P.E. de, Gansevoort, R.T., Drenth, J.P., Wetzels, J.F.M., Faculteit Medische Wetenschappen/UMCG, Groningen Institute for Organ Transplantation (GIOT), Lifestyle Medicine (LM), Groningen Kidney Center (GKC), and Cardiovascular Centre (CVC)
- Subjects
medicine.medical_specialty ,Analyte ,SAMPLES ,Clinical Biochemistry ,Renal function ,urologic and male genital diseases ,Auto-immunity, transplantation and immunotherapy [N4i 4] ,GFR ,Specimen Handling ,chemistry.chemical_compound ,Limit of Detection ,Internal medicine ,medicine ,Humans ,DELAYED SEPARATION ,Molecular gastro-enterology and hepatology Membrane transport and intracellular motility [IGMD 2] ,Renal Insufficiency, Chronic ,Cystatin C ,Enzyme Assays ,Whole blood ,Detection limit ,Creatinine ,Models, Statistical ,biology ,Plasma samples ,SERUM CREATININE ,PLASMA ,Protein Stability ,Reproducibility of Results ,Enzymatic assay ,General Medicine ,ANALYTES ,female genital diseases and pregnancy complications ,Endocrinology ,chemistry ,Blood Preservation ,biology.protein ,Cystatin ,Stability ,Biomarkers ,Glomerular Filtration Rate - Abstract
Background: As yet little is known about the effect of delayed separation of whole blood stored at room temperature on the stability of the kidney function markers creatinine and cystatin C.Methods: We used plasma samples of 45 patients with a wide range of creatinine and cystatin C concentration. Samples were sent by post as whole blood, and differences in creatinine and cystatin C concentrations when measured (by enzymatic assay and PETIA, respectively) in plasma separated shortly after blood withdrawal or in plasma obtained after delayed separation at 24, 48 and 72 h. Intra- and inter-assay variability was assessed and total change limit was calculated to assess analyte stability.Results: Total change limit was 3.3% for creatinine and 3.9% for cystatin C. In whole blood creatinine and cystatin C remained stable up to 48 h. Delayed separation of whole blood did not induce more variability in measured concentrations of both analytes. Glomerular filtration rate estimated with the CKD-EPI equations showed less than 3 mL/min/1.73 m(2) difference when using creatinine or cystatin C concentration measured in plasma separated up to 48 h after blood withdrawal compared to plasma separated shortly after blood withdrawal. The new CKD-EPI equation that uses creatinine as well as cystatin C to estimate GFR showed even at 72 h less than 3 mL/min/1.73 m(2) difference.Conclusions: Creatinine and cystatin C remain stable in whole blood stored at room temperature up to 48 h before separation, and changes in these analytes during this time period do not affect variability and eGFR. (C) 2013 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
- Published
- 2013
5. Changes in renal risk factors versus renal function outcome during follow-up in a population-based cohort study
- Author
-
Halbesma, N., Jansen, D.F., Stolk, R.P., Jong, P.E. de, Gansevoort, R.T., PREVEND Study Grp, Science in Healthy Ageing & healthcaRE (SHARE), Life Course Epidemiology (LCE), Cardiovascular Centre (CVC), Lifestyle Medicine (LM), and Groningen Kidney Center (GKC)
- Subjects
CHRONIC KIDNEY-DISEASE ,Male ,medicine.medical_treatment ,PROGRESSION ,Blood Pressure ,Kidney ,Kidney Function Tests ,GLOMERULAR-FILTRATION-RATE ,Cohort Studies ,Risk Factors ,Prospective Studies ,Prospective cohort study ,renal risk factors ,PREDICTORS ,Netherlands ,GENERAL-POPULATION ,education.field_of_study ,Sex Characteristics ,Middle Aged ,PREVALENCE ,medicine.anatomical_structure ,Cholesterol ,Nephrology ,Female ,Hemodialysis ,SMOKING ,Cohort study ,Adult ,medicine.medical_specialty ,Population ,Renal function ,DIABETIC-NEPHROPATHY ,Internal medicine ,medicine ,Albuminuria ,Humans ,PREVEND ,Risk factor ,Renal Insufficiency, Chronic ,education ,Transplantation ,GENDER-DIFFERENCES ,SERUM CREATININE ,business.industry ,renal function ,medicine.disease ,Surgery ,Multivariate Analysis ,Linear Models ,business ,Kidney disease ,Follow-Up Studies - Abstract
Background. Chronic kidney disease is a growing public health problem worldwide. Previous studies have identified several predictors for renal function decline. However, these studies used a single measurement of these risk factors. Therefore, the aim of this study was to investigate whether besides the baseline values of these risk factors, changes in risk factors are associated with subsequent rate of renal function loss.Methods. Five thousand, six hundred and fifty-one participants in the Prevention of Renal and Vascular ENd-stage Disease (PREVEND) Study, a prospective, community-based cohort study, completed three screening visits during a follow-up of 6.5 years for detailed clinical and biochemical measurements. Change in renal function between the second and third screening rounds was chosen as the study parameter of interest. Changes in risk factors between the first and second screening rounds were incorporated as potential predictors for renal function loss in multivariable linear regression analyses. Based on the results of a previous study, gender-specific analyses were performed.Results. In males, an increase in urinary albumin excretion (UAE), systolic blood pressure (SBP) and cholesterol was associated with a subsequent higher rate of renal function loss, whereas in females, increases in glucose levels were associated with an increase in renal function. For males, the analyses showed that both the baseline values and the change in UAE and cholesterol were significant predictors for increased rate of renal function loss during subsequent follow-up. With respect to SBP, when taking also the change in this variable into account, the baseline value was no longer a significant predictor for renal function loss.Conclusions. The results of the present study show the value of screening programs including repeated measurements of risk factors. Furthermore, these data indicate that, besides baseline values of risk factors, the changes over time in these factors should also be taken into account when developing 'Renal Risk Scores' to identify subjects in the general population who are at risk for accelerated renal function deterioration.
- Published
- 2010
6. Cardiovascular effects of road traffic noise with adjustment for air pollution
- Author
-
Kluizenaar, Y. de, Miedema, H.M.E., Gansevoort, R.T., Jong, P.E. de, and TNO Bouw
- Subjects
Urban Development ,Built Environment ,Acoustics and Audiology - Abstract
This study investigates cardiovascular effects of road traffic noise, accounting for air pollution. Noise and particulate matter (PM10) exposure was assessed for the City of Groningen sample (N = 40 856), and a selection of subjects that next visited the outpatient clinic (PREVEND cohort; N = 8 592). Questionnaires and, for the cohort, measurements (e.g. systolic and diastolic blood pressure, BMI, cholesterol) provided cardiovascular endpoints, risk factors and confounders. For individual exposure assessment detailed spatial data (e.g traffic characteristics, buildings, screening objects) were used together with geographical information systems (GIS) and state-of-the-art modeling techniques. Road traffic noise was associated with antihypertensive medication use in the City of Groningen sample (unadjusted OR = 1.31 per 10 dB increase Lden). Adjusted odds ratios were significant for the 45-55 yr age group in the full model adjusted for PM10 (OR = 1.19), and adjusted odds ratios were significant for higher exposure (Lden > 55 dB; OR= 1.21; with adjustment for PM10 OR = 1.31). In the cohort the unadjusted odds ratio was 1.35 for hypertension. The adjusted odds ratio was again significant for the 45-55 yr age group.
- Published
- 2007
7. Hypertension and road traffic noise exposure
- Author
-
Kluizenaar, Y. de, Gansevoort, R.T., Miedema, H.M.E., Jong, P.E. de, and TNO Bouw en Ondergrond
- Subjects
Adult ,Male ,Questionnaires ,systolic blood pressure ,hypertension ,Health Traffic ,prevalence ,environmental exposure ,prevention study ,random sample ,self report ,Cohort Studies ,Odds Ratio ,cross-sectional study ,Humans ,controlled study ,human ,antihypertensive therapy ,Aged ,Netherlands ,disease association ,article ,diastolic blood pressure ,traffic noise ,risk assessment ,Middle Aged ,cohort analysis ,major clinical study ,female ,Noise, Transportation ,antihypertensive agent ,Automobiles ,Environmental Monitoring - Abstract
OBJECTIVE: The purpose of this study was to assess the relationship between road traffic noise exposure at home and the prevalence of hypertension. METHODS: We conducted cross-sectional analyses in a large random sample (N = 40,856) of inhabitants of Groningen City, and in a subsample (the Prevention of Renal and Vascular End-Stage Disease [PREVEND]) study cohort; N = 8592). RESULTS: Before adjustment for confounders, road traffic noise exposure was associated with self-reported use of antihypertensive medication in the city of Groningen sample (odds ratio [OR] = 1.31 per 10-dB increase in Lden). Adjusted odds ratios were significant for the subjects between 45 and 55 years old in the full model when adjusted for PM10 (OR = 1.19) and at higher exposure (Lden >55 dB) only (OR = 1.21; with adjustment for PM10, OR = 1.31). In the PREVEND cohort, the unadjusted odds ratio was 1.35 for hypertension (systolic and diastolic blood pressure >140 and >90 mm Hg, respectively, or use of antihypertensive medication). Again, the adjusted odds ratio was significant for subjects between 45 and 55 years old (OR = 1.27; with adjustment for PM10, OR = 1.39). CONCLUSIONS: Exposure to road traffic noise may be associated with hypertension in subjects who are between 45 and 55 years old. Associations seemed to be stronger at higher noise levels. ©2007The American College of Occupational and Environmental Medicine.
- Published
- 2007
8. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality
- Author
-
Coresh, J., Turin, T.C., Matsushita, K., Sang, Y., Ballew, S.H., Appel, L.J., Arima, H., Chadban, S.J., Cirillo, M., Djurdjev, O., Green, J.A., Heine, G.H., Inker, L.A., Irie, F., Ishani, A., Ix, J.H., Kovesdy, C.P., Marks, A., Ohkubo, T., Shalev, V., Shankar, A., Wen, C.P., Jong, P.E. de, Iseki, K., Stengel, B., Gansevoort, R.T., Levey, A.S., Wetzels, J.F.M., Coresh, J., Turin, T.C., Matsushita, K., Sang, Y., Ballew, S.H., Appel, L.J., Arima, H., Chadban, S.J., Cirillo, M., Djurdjev, O., Green, J.A., Heine, G.H., Inker, L.A., Irie, F., Ishani, A., Ix, J.H., Kovesdy, C.P., Marks, A., Ohkubo, T., Shalev, V., Shankar, A., Wen, C.P., Jong, P.E. de, Iseki, K., Stengel, B., Gansevoort, R.T., Levey, A.S., and Wetzels, J.F.M.
- Abstract
Item does not contain fulltext, IMPORTANCE: The established chronic kidney disease (CKD) progression end point of end-stage renal disease (ESRD) or a doubling of serum creatinine concentration (corresponding to a change in estimated glomerular filtration rate [GFR] of -57% or greater) is a late event. OBJECTIVE: To characterize the association of decline in estimated GFR with subsequent progression to ESRD with implications for using lesser declines in estimated GFR as potential alternative end points for CKD progression. Because most people with CKD die before reaching ESRD, mortality risk also was investigated. DATA SOURCES AND STUDY SELECTION: Individual meta-analysis of 1.7 million participants with 12,344 ESRD events and 223,944 deaths from 35 cohorts in the CKD Prognosis Consortium with a repeated measure of serum creatinine concentration over 1 to 3 years and outcome data. DATA EXTRACTION AND SYNTHESIS: Transfer of individual participant data or standardized analysis of outputs for random-effects meta-analysis conducted between July 2012 and September 2013, with baseline estimated GFR values collected from 1975 through 2012. MAIN OUTCOMES AND MEASURES: End-stage renal disease (initiation of dialysis or transplantation) or all-cause mortality risk related to percentage change in estimated GFR over 2 years, adjusted for potential confounders and first estimated GFR. RESULTS: The adjusted hazard ratios (HRs) of ESRD and mortality were higher with larger estimated GFR decline. Among participants with baseline estimated GFR of less than 60 mL/min/1.73 m2, the adjusted HRs for ESRD were 32.1 (95% CI, 22.3-46.3) for changes of -57% in estimated GFR and 5.4 (95% CI, 4.5-6.4) for changes of -30%. However, changes of -30% or greater (6.9% [95% CI, 6.4%-7.4%] of the entire consortium) were more common than changes of -57% (0.79% [95% CI, 0.52%-1.06%]). This association was strong and consistent across the length of the baseline period (1 to 3 years), baseline estimated GFR, age, diabetes status, or al
- Published
- 2014
9. ACE inhibition preserves heparan sulfate proteoglycans in the glomerular basement membrane of rats with established adriamycin nephropathy
- Author
-
Wapstra, F.H., Navis, G.J., Goor, H. van, Born, J. van den, Berden, J.H.M., Jong, P.E. de, Zeeuw, D. de, Groningen University Institute for Drug Exploration (GUIDE), Groningen Institute for Organ Transplantation (GIOT), Groningen Kidney Center (GKC), Lifestyle Medicine (LM), and Vascular Ageing Programme (VAP)
- Subjects
DECREASE ,ALBUMINURIA ,MONOCLONAL-ANTIBODY ,adriamycin nephrosis ,urogenital system ,PROTEINURIA ,Pathofysiologie, immunologie en behandeling van nieraandoeningen ,Pathophysiology, immunology and treatment of renal disease ,ACE inhibition ,IN-VITRO ,urologic and male genital diseases ,female genital diseases and pregnancy complications ,carbohydrates (lipids) ,heparan sulfate proteoglycans ,NEPHROTIC SYNDROME ,DIABETIC NEPHROPATHY ,CONVERTING-ENZYME-INHIBITION ,NEPHRITIS - Abstract
The gradual onset of the antiproteinuric effects of ACE inhibition suggests that structural effects on the glomerular basement membrane (GBM) may be involved in their renoprotective action. To test this hypothesis, we studied the effects of lisinopril (5 mg/kg/24 h) on proteinuria, focal glomerulosclerosis (FGS) and glomerular heparan sulfate (HS) proteoglycan (HSPG) GEM staining in rats with established Adriamycin nephrosis, Treatment was started 6 weeks after disease induction. As expected, lisinopril reduced blood pressure, proteinuria and the FGS score. In control rats, Adriamycin nephrosis was associated with significantly impaired GEM staining for both HSPG core protein (assessed from BL-31 staining) and HS staining (assessed from JM-403 staining) 12 weeks after disease induction. In rats treated with lisinopril (5 mg/kg/24 h) GEM stianing was significantly better preserved for HS as well as for HSPG core protein. These data suggest that structural effects on the GEM, improving glomerular permselectivity, may be involved in the renoprotective effects of ACE inhibition in proetinuria-induced renal damage. Copyright (C) 2000 S. Karger AG, Basel.
- Published
- 2001
10. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis
- Author
-
Mahmoodi, B.K., Matsushita, K., Woodward, M., Blankestijn, P.J., Cirillo, M., Ohkubo, T., Rossing, P., Sarnak, M.J., Stengel, B., Yamagishi, K., Yamashita, K., Zhang, L., Coresh, J., Jong, P.E. de, Astor, B.C., Wetzels, J.F., et al., Mahmoodi, B.K., Matsushita, K., Woodward, M., Blankestijn, P.J., Cirillo, M., Ohkubo, T., Rossing, P., Sarnak, M.J., Stengel, B., Yamagishi, K., Yamashita, K., Zhang, L., Coresh, J., Jong, P.E. de, Astor, B.C., Wetzels, J.F., and et al.
- Abstract
Item does not contain fulltext, BACKGROUND: Hypertension is the most prevalent comorbidity in individuals with chronic kidney disease. However, whether the association of the kidney disease measures, estimated glomerular filtration rate (eGFR) and albuminuria, with mortality or end-stage renal disease (ESRD) differs by hypertensive status is unknown. METHODS: We did a meta-analysis of studies selected according to Chronic Kidney Disease Prognosis Consortium criteria. Data transfer and analyses were done between March, 2011, and June, 2012. We used Cox proportional hazards models to estimate the hazard ratios (HR) of mortality and ESRD associated with eGFR and albuminuria in individuals with and without hypertension. FINDINGS: We analysed data for 45 cohorts (25 general population, seven high-risk, and 13 chronic kidney disease) with 1,127,656 participants, 364,344 of whom had hypertension. Low eGFR and high albuminuria were associated with mortality irrespective of hypertensive status in the general population and high-risk cohorts. All-cause mortality risk was 1.1-1.2 times higher in individuals with hypertension than in those without hypertension at preserved eGFR. A steeper relative risk gradient in individuals without hypertension than in those with hypertension at eGFR range 45-75 mL/min per 1.73 m(2) led to much the same mortality risk at lower eGFR. With a reference eGFR of 95 mL/min per 1.73 m(2) in each group to explicitly assess interaction, adjusted HR for all-cause mortality at eGFR 45 mL/min per 1.73 m(2) was 1.77 (95% CI 1.57-1.99) in individuals without hypertension versus 1.24 (1.11-1.39) in those with hypertension (p for overall interaction=0.0003). Similarly, for albumin-creatinine ratio of 300 mg/g (vs 5 mg/g), HR was 2.30 (1.98-2.68) in individuals without hypertension versus 2.08 (1.84-2.35) in those with hypertension (p for overall interaction=0.019). We recorded much the same results for cardiovascular mortality. The associations of eGFR and albuminuria with ESRD, however, d
- Published
- 2012
11. Exploration of the difference in incidence of renal replacement therapy between Flanders and the Netherlands--investigation of explanatory variables.
- Author
-
Visser, A., Noordzij, M., Gansevoort, R.T., Biesen, W. Van, Reijneveld, S.A., Jager, K.J., Jong, P.E. de, Izaks, G.J., Dijkstra, G.J., Meester, J. de, Hoitsma, A.J., Franssen, C.F., Visser, A., Noordzij, M., Gansevoort, R.T., Biesen, W. Van, Reijneveld, S.A., Jager, K.J., Jong, P.E. de, Izaks, G.J., Dijkstra, G.J., Meester, J. de, Hoitsma, A.J., and Franssen, C.F.
- Abstract
1 februari 2012, Item does not contain fulltext, AIM: This study investigates the difference in the incidence of renal replacement therapy (RRT) between Flanders and the Netherlands and possible explanations for this difference. METHODS: End-stage renal disease incidence data were obtained from the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA). Additional sources were the National Institute of Statistics (NIS), the Central Bureau of Statistics (CBS), the Organisation for Economic Cooperation and Development (OECD) health data and the WHO Health For All database (WHO-HFA). RESULTS: There is remarkable difference in incidence rate of RRT between Flanders and the Netherlands, with a higher rate in Flanders. This difference is already present in patients aged 45-64 years and increases with age, being >2-fold higher in subjects of >/= 75 years. With respect to the renal diagnoses leading to need for RRT, a higher share of especially diabetes mellitus type 2 and renovascular disease was observed in Flanders. Remarkably, the difference in incidence rate of RRT is not associated with a difference in survival on RRT, not even in the elderly, arguing against a restricted access to RRT in the Netherlands. In the general population, the expected number of healthy life years at birth is lower in Belgium than in the Netherlands, and in Belgium, the hospital discharge rates for diabetes, acute myocardial infarction and cerebrovascular accident and the number of coronary bypass procedures and percutaneous coronary interventions per capitum is higher, as is the prevalence of obesity. CONCLUSION: Our data do not support the assumption that the differences in RRT incidence in the elderly between Flanders and the Netherlands are due to a more restricted access to RRT in the Netherlands but may be due to differences in underlying comorbidity and life style between the two populations.
- Published
- 2012
12. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts
- Author
-
Astor, B.C., Matsushita, K., Gansevoort, R.T., Velde, M. van de, Woodward, M., Levey, A.S., Jong, P.E. de, Coresh, J., El-Nahas, M., Eckardt, K.U., Kasiske, B.L., Wright, J., Appel, L., Greene, T., Levin, A., Djurdjev, O., Wheeler, D.C., Landray, M.J., Townend, J.N., Emberson, J., Clark, L.E., Macleod, A., Marks, A., Ali, T., Fluck, N., Prescott, G., Smith, D.H., Weinstein, J.R., Johnson, E.S., Thorp, M.L., Wetzels, J.F.M., Blankestijn, P.J., Zuilen, A.D. van, Menon, V., Sarnak, M., Beck, G., Kronenberg, F., Kollerits, B., Froissart, M., Stengel, B., Metzger, M., Remuzzi, G., Ruggenenti, P., Perna, A., Heerspink, H.J., Brenner, B., Zeeuw, D. de, Rossing, P., Parving, H.H., Auguste, P., Veldhuis, K., Wang, Y., Camarata, L., Thomas, B., Manley, T., Astor, B.C., Matsushita, K., Gansevoort, R.T., Velde, M. van de, Woodward, M., Levey, A.S., Jong, P.E. de, Coresh, J., El-Nahas, M., Eckardt, K.U., Kasiske, B.L., Wright, J., Appel, L., Greene, T., Levin, A., Djurdjev, O., Wheeler, D.C., Landray, M.J., Townend, J.N., Emberson, J., Clark, L.E., Macleod, A., Marks, A., Ali, T., Fluck, N., Prescott, G., Smith, D.H., Weinstein, J.R., Johnson, E.S., Thorp, M.L., Wetzels, J.F.M., Blankestijn, P.J., Zuilen, A.D. van, Menon, V., Sarnak, M., Beck, G., Kronenberg, F., Kollerits, B., Froissart, M., Stengel, B., Metzger, M., Remuzzi, G., Ruggenenti, P., Perna, A., Heerspink, H.J., Brenner, B., Zeeuw, D. de, Rossing, P., Parving, H.H., Auguste, P., Veldhuis, K., Wang, Y., Camarata, L., Thomas, B., and Manley, T.
- Abstract
Item does not contain fulltext, We studied here the independent associations of estimated glomerular filtration rate (eGFR) and albuminuria with mortality and end-stage renal disease (ESRD) in individuals with chronic kidney disease (CKD). We performed a collaborative meta-analysis of 13 studies totaling 21,688 patients selected for CKD of diverse etiology. After adjustment for potential confounders and albuminuria, we found that a 15 ml/min per 1.73 m(2) lower eGFR below a threshold of 45 ml/min per 1.73 m(2) was significantly associated with mortality and ESRD (pooled hazard ratios (HRs) of 1.47 and 6.24, respectively). There was significant heterogeneity between studies for both HR estimates. After adjustment for risk factors and eGFR, an eightfold higher albumin- or protein-to-creatinine ratio was significantly associated with mortality (pooled HR 1.40) without evidence of significant heterogeneity and with ESRD (pooled HR 3.04), with significant heterogeneity between HR estimates. Lower eGFR and more severe albuminuria independently predict mortality and ESRD among individuals selected for CKD, with the associations stronger for ESRD than for mortality. Thus, these relationships are consistent with CKD stage classifications based on eGFR and suggest that albuminuria provides additional prognostic information among individuals with CKD.
- Published
- 2011
13. Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening.
- Author
-
Halbesma, N., Kuiken, D.S., Brantsma, A.H., Bakker, S.J., Wetzels, J.F.M., Zeeuw, D. de, Jong, P.E. de, Gansevoort, R.T., Halbesma, N., Kuiken, D.S., Brantsma, A.H., Bakker, S.J., Wetzels, J.F.M., Zeeuw, D. de, Jong, P.E. de, and Gansevoort, R.T.
- Abstract
Item does not contain fulltext, Macroalbuminuria, erythrocyturia, and impaired renal function are strong predictors of poor renal outcome in patients with known renal disease. However, the yield of mass screening for these variables to identify individuals who are at risk for GFR loss is yet unknown in a Western population. With the use of data from the Prevention of Renal and Vascular End-Stage Disease (PREVEND) study, a prospective, population-based cohort study, the cardiovascular and renal prognosis was investigated in patients with classical renal risk markers: Macroalbuminuria (> or =300 mg albumin/24 h urine), erythrocyturia (> or =250 erythrocytes/L, without leukocyturia), and impaired renal function (both 24-h creatinine clearance and Modification of Diet in Renal Disease clearance below the fifth percentile of age- and gender-matched control subjects). The 8592 patients who were included in this study were followed for a 4-yr period. We identified 134 patients with macroalbuminuria, 128 with erythrocyturia, and 103 with impaired renal function. There was only a little overlap among the three groups. The prevalence of macroalbuminuria, erythrocyturia, and impaired renal function was calculated to be in the general population 0.6, 1.3, and 0.9%, respectively. In all three groups, fewer than 30% of patients were known to have this laboratory abnormality before screening. The incidence of cardiovascular disease was high in the macroalbuminuria group (e.g., the age- and gender-adjusted hazard ratio for mortality as a result of cardiovascular disease is 2.6 [1.1 to 6.0]) and for the impaired renal function group (3.4 [1.5 to 8.0]). After a mean follow-up of 4.2 yr, the macroalbuminuria group showed a -7.2 ml/min per 1.73 m2 estimated GFR (eGFR) loss, compared with -2.3 ml/min per 1.73 m2 in the control group (difference P < 0.001), whereas the rate of eGFR loss in the impaired renal function group (-0.2 ml/min per 1.73 m2; P = 0.18) and the erythrocyturia group (-2.6 ml/min per 1.73 m2) was no
- Published
- 2006
14. Membrane Biocompatibility Does Not Affect Whole Body Protein Metabolism during Dialysis
- Author
-
Veeneman, J.M., Kingma, H.A., Stellaard, F., Jong, P.E. de, Reijngoud, D.-J., and Huisman, R.M.
- Abstract
Abstract Background: Protein-calorie malnutrition is present in 3050% of dialysis patients. The lack of biocompatibility of the dialysis membrane, which results in low-grade inflammation, could be responsible for this malnutrition. We investigated whether protein-energy malnutrition could be partly due to incompatibility of the dialyzer during the dialysis session. Methods: Five patients were dialyzed during 2 periods of 3 weeks (cross-over) with either a single-use low-flux polysulfone or cellulose triacetate (biocompatible) or a single-use cuprophan (bio-incompatible) membrane. As a measure of whole body protein metabolism, a primed constant infusion of L-[1-13 C]-valine was used during a 4-hour dialysis session. Results: Cuprophan was a more powerful activator of the complement system than other membranes. Protein metabolism parameters during both study protocols were not different and resulted in the same protein balance during polysulfone/cellulose triacetate (15 ± 3) and cuprophan (13 ± 2 μmol/kg/h) dialysis. Conclusion: In stable hemodialysis patients with no apparent complications, protein metabolism during dialysis is not affected by the compatibility of the dialysis membrane.Copyright © 2005 S. Karger AG, Basel- Published
- 2005
15. Book Reviews
- Author
-
Schoffeleers, M., Schuch, B., Broeke, W., Buijtenhuijs, R., Bernus et al., S., Vickers, Adrian, Davis, Richard B., Bakel, M.A., Daal, Luis H., Turner, Victor W., Locher, G.W., Wessing, Robert, Claessen, H.J.M., Amri Baharuddin, Shamsul, Quang, Truong, Segalen, Martine, Syukri, I., Ward Gailey, Christine, Liebig-Hundius, Ingrid, Schulte Nordholt, Nico G., Tambiah, S.J., Carstens, Sharon A., Meyer, H., Buijtenhuijs, R., Daniëls, Alfred E., Kähler, Hans, Vickerman, Andrew, Renard-Clamagirand, Brigitte, Wijeyewardene, Gehan, Nothofer, Bernd, Hinzler, H.I.R., Daniëls, Alfred E., Baker, Victoria J., Frobenius, Leo, Lewis, I.M., Hoefte, Rosemarijn, Doorn, Jacques, Idema, W.L., Platenkamp, J.D.M., Schoenaker, H.C.G., Groen, P.M.H., Bargatzky, Thomas, Beek, W.E.A., Teeuw, A., Casajus, Dominique, Schulte Nordholt, Henke, Jackson, Anthony, Josselin de Jong, P.E., Salmon, Claudine, and Josselin de Jong, P.E. de
- Published
- 1989
- Full Text
- View/download PDF
16. Book Reviews
- Author
-
Wolf, J.J., Nooy-Palm, C.H.M., Leopold, Joan, Jaquet, F.G.P., Emst, P., King, Victor T., Graaf, H.J., Landwehr, J., Muller, Jean-Claude, Lydall, Jean, Reenen, G.J., Soebagijo I.N., ?, Josselin de Jong, P.E. de, Hooker, M.B., Reid, Anthony, Diffie, Bailey W., Postel-Coster, Els, Weijden, Gera, Buschkens, W.F.L., Jaquet, F.G.P., Claessen, Henri J.M., Shack, William A., Niehof, Anke, Rienks, Sjoukje, James, Wendy, Rosaldo, Renato, Benda-Beckmann, Franz, Hill, David T., Claessen, Henri J.M., Josselin de Jong, P.E., Presvelou, Clio, Graaf, H.J., Beekman, E.M., Kahn, Joel S., Bastin, J., Lohuizen-de Leeuw, J.E., Benda-Beckmann, Franz, Claessen, Henri J.M., Salmon, Claudine, Hekker, M., Lundström-Burghoorn, W., and Peletz, Michael G.
- Published
- 1982
- Full Text
- View/download PDF
17. Dose of doxorubicin determines severity of renal damage and responsiveness to ACE-inhibition in experimental nephrosis - renal effects of ACE inhibition
- Author
-
Wapstra, F.H., Goor, H. van, Jong, P.E. de, Navis, G., and Zeeuw, D. de
- Published
- 1999
- Full Text
- View/download PDF
18. Percevoir la pertinence
- Author
-
de Jong, P.E. de Josselin
19. Percevoir la pertinence
- Author
-
de Jong, P.E. de Josselin, primary
- Published
- 1983
- Full Text
- View/download PDF
20. Book Reviews
- Author
-
Baker, Victoria J., primary, Jackson, Anthony, additional, Bargatzky, Thomas, additional, Bakel, M.A., additional, Beek, W.E.A., additional, Turner, Victor W., additional, Broeke, W., additional, Meyer, H., additional, Buijtenhuijs, R., additional, Bernus et al., S., additional, Casajus, Dominique, additional, Claessen, H.J.M., additional, Ward Gailey, Christine, additional, Daniëls, Alfred E., additional, Davis, Richard B., additional, Wijeyewardene, Gehan, additional, Groen, P.M.H., additional, Doorn, Jacques, additional, Hoefte, Rosemarijn, additional, Daal, Luis H., additional, Idema, W.L., additional, Salmon, Claudine, additional, Josselin de Jong, P.E., additional, Carstens, Sharon A., additional, Josselin de Jong, P.E. de, additional, Wessing, Robert, additional, Locher, G.W., additional, Segalen, Martine, additional, Nothofer, Bernd, additional, Kähler, Hans, additional, Platenkamp, J.D.M., additional, Renard-Clamagirand, Brigitte, additional, Schoenaker, H.C.G., additional, Frobenius, Leo, additional, Schoffeleers, M., additional, Lewis, I.M., additional, Schuch, B., additional, Liebig-Hundius, Ingrid, additional, Schulte Nordholt, Henke, additional, Tambiah, S.J., additional, Schulte Nordholt, Nico G., additional, Amri Baharuddin, Shamsul, additional, Teeuw, A., additional, Syukri, I., additional, Quang, Truong, additional, Vickerman, Andrew, additional, Vickers, Adrian, additional, and Hinzler, H.I.R., additional
- Published
- 1989
- Full Text
- View/download PDF
21. Urinary albumin excretion is related to cardiovascular risk indicators, not to flow-mediated vasodilation, in apparently healthy subjects
- Author
-
Diercks, Gilles F.H., Stroes, Erik S.G., Boven, Ad J. van, Roon, Arie M. van, Hillege, Hans L., Jong, P.E. de, Smit, Andries J., Gans, Rijk O.B., Crijns, Harry J.G.M., Rabelink, Ton J., and Gilst, Wiek H. van
- Subjects
- *
ENDOTHELIUM diseases , *CARDIOVASCULAR diseases - Abstract
Based on studies in diabetic and hypertensive populations it has been postulated that early endothelial dysfunction is the mechanism responsible for the increased cardiovascular risk in microalbuminuric subjects. We evaluated the relation between microalbuminuria and endothelial dysfunction, assessed as flow-mediated dilation of the brachial artery, in an apparently healthy population. Within the framework of the PREVEND Intervention Trial non-hypertensive and non-hypercholesterolemic subjects were recruited on the basis of reproducible microalbuminuria. Using high-resolution ultrasound, flow-mediated dilation and nitroglycerin-mediated dilation of the brachial artery was assessed to measure endothelium-dependent and endothelium-independent responses, respectively. For the current study subjects with diabetes mellitus, clinical atherosclerosis, and macroalbuminuria were excluded from the analyses. We studied 421 men and 233 women (mean age (SD) 50 (12)). Increasing levels of urinary albumin excretion were accompanied by a significant increase in age, percentage men, systolic and diastolic blood pressure, body mass index, and serum triglycerides, whereas there was no decrease of flow-mediated vasodilation or nitroglycerin-mediated vasodilation. Adjusted for age and sex, urinary albumin excretion was significantly related to systolic (r=0.19, P<0.001) and diastolic (r=0.16, P<0.001) blood pressure, body mass index (r=0.18, P<0.001), and triglycerides (r=0.13, P=0.001), but not to flow-mediated vasodilation (r=−0.01, P=0.8). In contrast to blood pressure, body mass index, and triglycerides, there was no relation between urinary albumin excretion and flow-mediated vasodilation in apparently healthy subjects. These data suggest that the presence of atherogenic risk factors precedes the development of endothelial dysfunction in microalbuminuric, but otherwise healthy subjects. [Copyright &y& Elsevier]
- Published
- 2002
- Full Text
- View/download PDF
22. 'Eating Like a Blacksmith': Symbols in Kapsiki Ethno-Zoology
- Author
-
Beek, W.E.A. van and Josselin de Jong P.E. de
- Published
- 1982
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.